International Association for the Study of Lung Cancer: 11th Annual Targeted Therapies of the Treatment of Lung Cancer February 23, 2011

The IASLC: 11th Annual Targeted Therapies of the Treatment of Lung Cancer is an annual professional workshop that is open to all members of the IASLC (physicians, health professionals and scientists interested in lung cancer). The conference presents recent research in the area of targeted treatment therapies for lung cancer.

Edward Bradley will speak on the topic of "MEDI575: An Anti-PDGFRa mAb."